83 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
: Prospectus Department, 200 West Street, New York, New York 10282, telephone:866-471-2526, facsimile:212-902-9316,e-mail:prospectus-ny@ny.email.gs.com … ; or Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, by email
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
11 Jun 21
Other Events
7:24am
professor, Department of Hematology, Rigshospitalet; Copenhagen, Denmark.
ACTIVATE Results Summary
The Phase 3 ACTIVATE trial of mitapivat achieved its … Glenthøj, M.D., Department of Hematology, Rigshospitalet Copenhagen, Denmark
Mitapivat Clinical Development
ACTIVATE and ACTIVATE-T are intended
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
., Attn: Prospectus Department, 200 West Street, New York, NY 10282, telephone: 866-471-2526, facsimile: 212-902-9316, e-mail: prospectus-ny
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
or are refractory to available therapies have few, if any, treatment options,” said Hagop M. Kantarjian, M.D., professor and chair of the Department
8-K
EX-99.1
5lupoo8a
3 Jun 19
Other Events
4:02pm
8-K
EX-10.1
sb0r fiy6gzj83gk9x
23 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
ckl6a7u3y58eusr w0
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
S-3ASR
EX-1.2
31kc87r
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-1.1
hjumqwsw 2tgowrho
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-10.1
zl52bz0rch1okv87gqks
26 Nov 14
Entry into a Material Definitive Agreement
12:00am
S-8
EX-99.1
ay2y2
13 Jun 23
Registration of securities for employees
4:13pm
8-K
EX-99.1
l4lntd
15 Oct 14
Regulation FD Disclosure
12:00am